| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Immunohistochemistry | 27 | 2024 | 11067 | 1.500 |
Why?
|
| Lymphocytosis | 3 | 2024 | 121 | 1.300 |
Why?
|
| Gastritis | 6 | 2024 | 199 | 1.230 |
Why?
|
| Barrett Esophagus | 4 | 2020 | 492 | 1.230 |
Why?
|
| Celiac Disease | 9 | 2024 | 819 | 1.210 |
Why?
|
| Pathology, Clinical | 6 | 2024 | 376 | 1.110 |
Why?
|
| Principal Component Analysis | 4 | 2022 | 942 | 1.030 |
Why?
|
| Intestinal Mucosa | 14 | 2024 | 3031 | 0.850 |
Why?
|
| Laboratories | 5 | 2019 | 462 | 0.830 |
Why?
|
| Intestinal Atresia | 1 | 2022 | 68 | 0.770 |
Why?
|
| Adenomatous Polyposis Coli | 1 | 2022 | 219 | 0.710 |
Why?
|
| Colonic Polyps | 2 | 2022 | 552 | 0.710 |
Why?
|
| Arsenic | 4 | 2024 | 361 | 0.680 |
Why?
|
| Helicobacter pylori | 5 | 2023 | 382 | 0.660 |
Why?
|
| Ileitis | 1 | 2019 | 39 | 0.660 |
Why?
|
| Severe Combined Immunodeficiency | 1 | 2022 | 229 | 0.650 |
Why?
|
| Colitis | 8 | 2024 | 1234 | 0.600 |
Why?
|
| Colitis, Ulcerative | 6 | 2022 | 1920 | 0.580 |
Why?
|
| Helicobacter Infections | 4 | 2023 | 392 | 0.560 |
Why?
|
| Esophagus | 4 | 2018 | 1036 | 0.540 |
Why?
|
| Time | 1 | 2018 | 545 | 0.540 |
Why?
|
| Benchmarking | 3 | 2021 | 1045 | 0.530 |
Why?
|
| Air Pollution | 8 | 2023 | 2351 | 0.510 |
Why?
|
| Malabsorption Syndromes | 3 | 2023 | 135 | 0.500 |
Why?
|
| Gastritis, Atrophic | 1 | 2015 | 32 | 0.500 |
Why?
|
| Gastric Mucosa | 6 | 2023 | 603 | 0.490 |
Why?
|
| Intestinal Diseases | 3 | 2023 | 503 | 0.480 |
Why?
|
| Colon | 8 | 2024 | 1791 | 0.480 |
Why?
|
| Amyloidosis | 5 | 2020 | 865 | 0.480 |
Why?
|
| Gastroesophageal Reflux | 2 | 2020 | 821 | 0.460 |
Why?
|
| Soft Tissue Neoplasms | 7 | 2023 | 1158 | 0.460 |
Why?
|
| Gastrointestinal Tract | 1 | 2020 | 834 | 0.460 |
Why?
|
| Child | 44 | 2024 | 80154 | 0.450 |
Why?
|
| Models, Statistical | 7 | 2022 | 5081 | 0.450 |
Why?
|
| Humans | 186 | 2024 | 761222 | 0.440 |
Why?
|
| Folic Acid | 4 | 2024 | 1323 | 0.440 |
Why?
|
| Germ-Line Mutation | 1 | 2022 | 1852 | 0.430 |
Why?
|
| Tissue Fixation | 2 | 2011 | 241 | 0.430 |
Why?
|
| Vascular Neoplasms | 1 | 2015 | 166 | 0.430 |
Why?
|
| Wnt Proteins | 3 | 2024 | 720 | 0.420 |
Why?
|
| Biopsy | 15 | 2024 | 6781 | 0.410 |
Why?
|
| Seasons | 2 | 2016 | 1518 | 0.410 |
Why?
|
| Esophagitis | 1 | 2014 | 165 | 0.410 |
Why?
|
| Regression Analysis | 6 | 2018 | 6345 | 0.400 |
Why?
|
| Laboratories, Hospital | 2 | 2016 | 192 | 0.400 |
Why?
|
| Liposarcoma | 1 | 2015 | 289 | 0.390 |
Why?
|
| Duodenum | 5 | 2024 | 491 | 0.380 |
Why?
|
| Vena Cava, Inferior | 1 | 2015 | 459 | 0.380 |
Why?
|
| Linear Models | 4 | 2022 | 5869 | 0.380 |
Why?
|
| Data Interpretation, Statistical | 2 | 2018 | 2691 | 0.380 |
Why?
|
| Metaplasia | 3 | 2023 | 324 | 0.380 |
Why?
|
| Staining and Labeling | 2 | 2017 | 1080 | 0.370 |
Why?
|
| Eosinophilic Esophagitis | 3 | 2019 | 199 | 0.370 |
Why?
|
| Inflammatory Bowel Diseases | 6 | 2023 | 2421 | 0.360 |
Why?
|
| Proteins | 2 | 2022 | 5993 | 0.350 |
Why?
|
| Intestinal Polyposis | 1 | 2010 | 42 | 0.340 |
Why?
|
| Diarrhea, Infantile | 2 | 2021 | 100 | 0.330 |
Why?
|
| Fibroma | 3 | 2014 | 190 | 0.330 |
Why?
|
| Mesenchymoma | 1 | 2009 | 49 | 0.330 |
Why?
|
| Mucolipidoses | 2 | 2023 | 82 | 0.330 |
Why?
|
| Exercise | 5 | 2023 | 5874 | 0.330 |
Why?
|
| Algorithms | 9 | 2022 | 14025 | 0.320 |
Why?
|
| Indians, North American | 2 | 2023 | 351 | 0.320 |
Why?
|
| Receptor, erbB-2 | 4 | 2023 | 2553 | 0.310 |
Why?
|
| Peripheral Nervous System Neoplasms | 3 | 2014 | 133 | 0.310 |
Why?
|
| Glutens | 3 | 2023 | 240 | 0.310 |
Why?
|
| DNA, Mitochondrial | 2 | 2024 | 865 | 0.300 |
Why?
|
| Esophagogastric Junction | 2 | 2020 | 347 | 0.300 |
Why?
|
| Air Pollutants | 4 | 2023 | 2889 | 0.290 |
Why?
|
| Stroke | 4 | 2023 | 9721 | 0.290 |
Why?
|
| Female | 101 | 2024 | 392552 | 0.290 |
Why?
|
| Colonoscopy | 4 | 2022 | 1395 | 0.290 |
Why?
|
| New York City | 5 | 2024 | 730 | 0.280 |
Why?
|
| Pathology, Surgical | 1 | 2008 | 151 | 0.280 |
Why?
|
| Male | 94 | 2024 | 360703 | 0.280 |
Why?
|
| Prenatal Exposure Delayed Effects | 4 | 2022 | 2517 | 0.280 |
Why?
|
| Fibromatosis, Aggressive | 3 | 2013 | 126 | 0.280 |
Why?
|
| Environmental Pollutants | 3 | 2022 | 1276 | 0.270 |
Why?
|
| Practice Guidelines as Topic | 3 | 2024 | 7400 | 0.270 |
Why?
|
| Diarrhea | 4 | 2021 | 1316 | 0.270 |
Why?
|
| Schools | 1 | 2015 | 1483 | 0.270 |
Why?
|
| Dextran Sulfate | 3 | 2024 | 258 | 0.260 |
Why?
|
| Computer Graphics | 2 | 2018 | 338 | 0.260 |
Why?
|
| Cadmium | 2 | 2024 | 215 | 0.260 |
Why?
|
| Bacterial Toxins | 2 | 2023 | 923 | 0.250 |
Why?
|
| Colorectal Neoplasms | 2 | 2022 | 6919 | 0.250 |
Why?
|
| Reproducibility of Results | 16 | 2024 | 20118 | 0.250 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2011 | 951 | 0.250 |
Why?
|
| Bayes Theorem | 5 | 2022 | 2329 | 0.240 |
Why?
|
| Particulate Matter | 5 | 2023 | 2597 | 0.240 |
Why?
|
| Adolescent | 30 | 2024 | 88300 | 0.240 |
Why?
|
| Environmental Exposure | 9 | 2023 | 4479 | 0.230 |
Why?
|
| Wetlands | 1 | 2024 | 13 | 0.230 |
Why?
|
| Helicobacter heilmannii | 1 | 2023 | 6 | 0.230 |
Why?
|
| Glycoproteins | 3 | 2024 | 2203 | 0.230 |
Why?
|
| Histological Techniques | 2 | 2016 | 193 | 0.230 |
Why?
|
| Prealbumin | 3 | 2020 | 247 | 0.220 |
Why?
|
| Myxosarcoma | 1 | 2023 | 11 | 0.220 |
Why?
|
| Myosin Type V | 1 | 2023 | 32 | 0.220 |
Why?
|
| Lymphocytes | 2 | 2024 | 2603 | 0.220 |
Why?
|
| Gastrointestinal Stromal Tumors | 1 | 2009 | 617 | 0.220 |
Why?
|
| Neurogenic Inflammation | 1 | 2023 | 33 | 0.220 |
Why?
|
| Poverty | 1 | 2015 | 2691 | 0.220 |
Why?
|
| Sciatic Neuropathy | 2 | 2013 | 76 | 0.210 |
Why?
|
| Child, Preschool | 20 | 2024 | 42225 | 0.210 |
Why?
|
| Intestines | 4 | 2022 | 1908 | 0.210 |
Why?
|
| Adenocarcinoma, Papillary | 1 | 2003 | 84 | 0.210 |
Why?
|
| Feeding Behavior | 1 | 2015 | 3183 | 0.210 |
Why?
|
| Multiple Sclerosis | 3 | 2014 | 3222 | 0.210 |
Why?
|
| Cystadenoma, Serous | 1 | 2003 | 100 | 0.210 |
Why?
|
| Arsenicals | 1 | 2023 | 117 | 0.210 |
Why?
|
| Lipomatosis | 2 | 2013 | 112 | 0.200 |
Why?
|
| Dietary Supplements | 3 | 2024 | 3410 | 0.200 |
Why?
|
| Trace Elements | 1 | 2024 | 193 | 0.200 |
Why?
|
| Enterocytes | 3 | 2023 | 220 | 0.200 |
Why?
|
| Neoplasms, Muscle Tissue | 1 | 2002 | 67 | 0.200 |
Why?
|
| Sarcoma | 4 | 2017 | 1800 | 0.200 |
Why?
|
| Retrospective Studies | 27 | 2024 | 80675 | 0.200 |
Why?
|
| Gastrointestinal Diseases | 3 | 2020 | 1201 | 0.200 |
Why?
|
| Infant | 17 | 2023 | 36170 | 0.200 |
Why?
|
| Motor Activity | 3 | 2018 | 2712 | 0.200 |
Why?
|
| Diet, Gluten-Free | 3 | 2023 | 283 | 0.200 |
Why?
|
| Qa-SNARE Proteins | 1 | 2021 | 52 | 0.190 |
Why?
|
| Duodenitis | 1 | 2021 | 20 | 0.190 |
Why?
|
| Pathology | 2 | 2017 | 269 | 0.190 |
Why?
|
| Flame Retardants | 1 | 2022 | 96 | 0.190 |
Why?
|
| Fibrosarcoma | 1 | 2023 | 308 | 0.190 |
Why?
|
| Hemangiopericytoma | 1 | 2001 | 71 | 0.190 |
Why?
|
| Saccharomyces | 2 | 2013 | 62 | 0.190 |
Why?
|
| Colonic Neoplasms | 2 | 2010 | 2527 | 0.190 |
Why?
|
| Recovery of Function | 3 | 2023 | 2981 | 0.180 |
Why?
|
| Vitamin B 12 | 1 | 2024 | 524 | 0.180 |
Why?
|
| Bone Neoplasms | 3 | 2023 | 2527 | 0.180 |
Why?
|
| Hemangioma | 2 | 2019 | 727 | 0.180 |
Why?
|
| Neurons, Afferent | 1 | 2023 | 498 | 0.180 |
Why?
|
| Adult | 55 | 2024 | 221120 | 0.180 |
Why?
|
| Selenium | 1 | 2024 | 416 | 0.180 |
Why?
|
| Pericytes | 1 | 2023 | 295 | 0.180 |
Why?
|
| Food Supply | 2 | 2024 | 539 | 0.180 |
Why?
|
| Food | 2 | 2023 | 768 | 0.180 |
Why?
|
| Research Design | 3 | 2021 | 6180 | 0.180 |
Why?
|
| I-kappa B Kinase | 1 | 2021 | 249 | 0.170 |
Why?
|
| Pancreas | 5 | 2017 | 1684 | 0.170 |
Why?
|
| Goiter | 1 | 2000 | 87 | 0.170 |
Why?
|
| Leiomyosarcoma | 2 | 2017 | 422 | 0.170 |
Why?
|
| Immunologic Tests | 1 | 2020 | 104 | 0.170 |
Why?
|
| Computer Simulation | 4 | 2018 | 6224 | 0.170 |
Why?
|
| Microvilli | 2 | 2023 | 234 | 0.170 |
Why?
|
| Epilepsy | 4 | 2016 | 3304 | 0.170 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2021 | 282 | 0.170 |
Why?
|
| Duodenal Diseases | 1 | 2020 | 99 | 0.170 |
Why?
|
| Disorders of Sex Development | 1 | 2021 | 128 | 0.170 |
Why?
|
| Formaldehyde | 2 | 2011 | 357 | 0.170 |
Why?
|
| Haploinsufficiency | 2 | 2022 | 336 | 0.170 |
Why?
|
| Complex Mixtures | 1 | 2019 | 29 | 0.170 |
Why?
|
| Coronary Care Units | 2 | 1998 | 235 | 0.170 |
Why?
|
| Spinal Canal | 1 | 2019 | 41 | 0.170 |
Why?
|
| Growth and Development | 1 | 2019 | 46 | 0.160 |
Why?
|
| Orbital Neoplasms | 1 | 2001 | 222 | 0.160 |
Why?
|
| X-Linked Inhibitor of Apoptosis Protein | 1 | 2019 | 61 | 0.160 |
Why?
|
| Endoscopy, Digestive System | 2 | 2019 | 353 | 0.160 |
Why?
|
| Short Bowel Syndrome | 1 | 2023 | 353 | 0.160 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 2013 | 3366 | 0.160 |
Why?
|
| Immune System Diseases | 1 | 2021 | 255 | 0.160 |
Why?
|
| Adenocarcinoma, Mucinous | 1 | 2003 | 517 | 0.160 |
Why?
|
| Body Mass Index | 6 | 2024 | 12952 | 0.160 |
Why?
|
| Fecal Impaction | 1 | 2018 | 32 | 0.160 |
Why?
|
| Coloring Agents | 2 | 2023 | 561 | 0.160 |
Why?
|
| Inflammation | 6 | 2023 | 10759 | 0.160 |
Why?
|
| Metabolism, Inborn Errors | 1 | 2021 | 284 | 0.160 |
Why?
|
| Chondroma | 1 | 2018 | 53 | 0.160 |
Why?
|
| Eye Abnormalities | 1 | 2021 | 241 | 0.150 |
Why?
|
| Frozen Sections | 1 | 2019 | 153 | 0.150 |
Why?
|
| DNA Copy Number Variations | 2 | 2024 | 2024 | 0.150 |
Why?
|
| Receptors, IgG | 1 | 2021 | 558 | 0.150 |
Why?
|
| Cytomegalovirus Infections | 2 | 2021 | 828 | 0.150 |
Why?
|
| Mixed Tumor, Malignant | 1 | 2017 | 16 | 0.150 |
Why?
|
| Muscles | 1 | 2002 | 1568 | 0.150 |
Why?
|
| Ampulla of Vater | 1 | 2018 | 149 | 0.150 |
Why?
|
| Stem Cell Niche | 1 | 2021 | 345 | 0.140 |
Why?
|
| Middle Aged | 52 | 2024 | 220858 | 0.140 |
Why?
|
| Enterocolitis, Necrotizing | 1 | 2021 | 326 | 0.140 |
Why?
|
| Amyloid Neuropathies, Familial | 1 | 2020 | 166 | 0.140 |
Why?
|
| Probiotics | 2 | 2013 | 378 | 0.140 |
Why?
|
| Enteroendocrine Cells | 1 | 2018 | 79 | 0.140 |
Why?
|
| Fetal Blood | 1 | 2024 | 1348 | 0.140 |
Why?
|
| Enterotoxins | 1 | 2018 | 365 | 0.140 |
Why?
|
| Colectomy | 1 | 2022 | 686 | 0.140 |
Why?
|
| Immunophenotyping | 2 | 2020 | 1867 | 0.140 |
Why?
|
| Environmental Monitoring | 2 | 2023 | 1460 | 0.140 |
Why?
|
| Antigens, CD | 3 | 2021 | 4009 | 0.140 |
Why?
|
| Total Quality Management | 1 | 1998 | 262 | 0.140 |
Why?
|
| Autoimmunity | 2 | 2022 | 1356 | 0.140 |
Why?
|
| Codon, Nonsense | 1 | 2018 | 284 | 0.140 |
Why?
|
| New York | 4 | 2021 | 875 | 0.140 |
Why?
|
| Ileum | 1 | 2019 | 557 | 0.140 |
Why?
|
| Receptors, Interleukin-10 | 1 | 2016 | 50 | 0.140 |
Why?
|
| Reimbursement Mechanisms | 2 | 2012 | 667 | 0.140 |
Why?
|
| Chromosomes, Human, Pair 14 | 1 | 2017 | 286 | 0.130 |
Why?
|
| Oral Ulcer | 1 | 2017 | 96 | 0.130 |
Why?
|
| Quality Control | 2 | 2016 | 833 | 0.130 |
Why?
|
| Aged | 37 | 2024 | 169292 | 0.130 |
Why?
|
| United States | 13 | 2024 | 72341 | 0.130 |
Why?
|
| Autoimmune Diseases | 2 | 2024 | 2244 | 0.130 |
Why?
|
| Penetrance | 2 | 2015 | 382 | 0.130 |
Why?
|
| Radiography, Interventional | 3 | 2017 | 1122 | 0.130 |
Why?
|
| Clostridium Infections | 2 | 2023 | 557 | 0.130 |
Why?
|
| Transcription Factor RelA | 1 | 2017 | 254 | 0.130 |
Why?
|
| Fatigue | 1 | 2023 | 1550 | 0.130 |
Why?
|
| Histocytochemistry | 3 | 2014 | 697 | 0.130 |
Why?
|
| Heart Failure, Systolic | 1 | 2017 | 135 | 0.130 |
Why?
|
| Enterocolitis | 1 | 2017 | 106 | 0.130 |
Why?
|
| Skin Ulcer | 1 | 2017 | 130 | 0.130 |
Why?
|
| Energy Metabolism | 3 | 2017 | 2877 | 0.130 |
Why?
|
| Neurulation | 1 | 2015 | 9 | 0.130 |
Why?
|
| Hospital Units | 1 | 1997 | 142 | 0.130 |
Why?
|
| Syndrome | 1 | 2022 | 3271 | 0.130 |
Why?
|
| Clinical Laboratory Information Systems | 1 | 2016 | 108 | 0.130 |
Why?
|
| Abdomen | 1 | 2022 | 1128 | 0.130 |
Why?
|
| Eosinophilia | 1 | 2020 | 557 | 0.130 |
Why?
|
| Telemetry | 1 | 1997 | 199 | 0.130 |
Why?
|
| Motor Cortex | 1 | 2023 | 1006 | 0.130 |
Why?
|
| Decision Support Techniques | 2 | 2017 | 2004 | 0.130 |
Why?
|
| Lymphohistiocytosis, Hemophagocytic | 1 | 2019 | 269 | 0.130 |
Why?
|
| Gastrulation | 1 | 2015 | 36 | 0.120 |
Why?
|
| Validation Studies as Topic | 1 | 2015 | 162 | 0.120 |
Why?
|
| Cardiomyopathies | 2 | 2020 | 2021 | 0.120 |
Why?
|
| Genomic Imprinting | 1 | 2017 | 323 | 0.120 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2021 | 781 | 0.120 |
Why?
|
| Epitopes | 2 | 2023 | 2504 | 0.120 |
Why?
|
| Mutation, Missense | 2 | 2021 | 2567 | 0.120 |
Why?
|
| Case-Control Studies | 6 | 2024 | 22174 | 0.120 |
Why?
|
| Biostatistics | 1 | 2017 | 164 | 0.120 |
Why?
|
| Genetic Testing | 4 | 2018 | 3537 | 0.120 |
Why?
|
| Hypoglycemia | 2 | 2017 | 883 | 0.120 |
Why?
|
| Sample Size | 1 | 2018 | 843 | 0.120 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2018 | 3493 | 0.120 |
Why?
|
| Spinal Cord Injuries | 1 | 2023 | 924 | 0.120 |
Why?
|
| Capillary Permeability | 1 | 2018 | 773 | 0.120 |
Why?
|
| Blood Pressure Monitoring, Ambulatory | 1 | 2017 | 244 | 0.120 |
Why?
|
| Monitoring, Ambulatory | 2 | 2016 | 355 | 0.120 |
Why?
|
| Magnetic Resonance Imaging, Interventional | 1 | 2017 | 187 | 0.120 |
Why?
|
| Virulence Factors | 1 | 2018 | 511 | 0.120 |
Why?
|
| Cryptococcus | 1 | 2014 | 28 | 0.120 |
Why?
|
| RNA, Messenger | 3 | 2018 | 12747 | 0.120 |
Why?
|
| Coronary Disease | 2 | 2021 | 5921 | 0.120 |
Why?
|
| Genes, Dominant | 1 | 2017 | 850 | 0.120 |
Why?
|
| Diagnosis, Differential | 9 | 2023 | 12976 | 0.120 |
Why?
|
| Central Nervous System Depressants | 1 | 2015 | 164 | 0.120 |
Why?
|
| Inferior Colliculi | 1 | 1995 | 72 | 0.120 |
Why?
|
| RNA, Neoplasm | 1 | 2017 | 748 | 0.120 |
Why?
|
| Signal Transduction | 12 | 2023 | 23419 | 0.120 |
Why?
|
| Fatty Acid-Binding Proteins | 1 | 2016 | 295 | 0.110 |
Why?
|
| Chondromatosis, Synovial | 1 | 2014 | 17 | 0.110 |
Why?
|
| Immunity, Cellular | 1 | 2020 | 1553 | 0.110 |
Why?
|
| Bursa, Synovial | 1 | 2014 | 25 | 0.110 |
Why?
|
| Ultrasonography, Doppler, Duplex | 1 | 2015 | 198 | 0.110 |
Why?
|
| Cryptococcosis | 1 | 2014 | 103 | 0.110 |
Why?
|
| Adiposity | 1 | 2024 | 1879 | 0.110 |
Why?
|
| Gastric Bypass | 2 | 2017 | 818 | 0.110 |
Why?
|
| Models, Biological | 2 | 2022 | 9458 | 0.110 |
Why?
|
| Osteochondroma | 1 | 2014 | 44 | 0.110 |
Why?
|
| Femoral Neoplasms | 1 | 2014 | 84 | 0.110 |
Why?
|
| Dominican Republic | 2 | 2024 | 77 | 0.110 |
Why?
|
| Carcinoma, Neuroendocrine | 1 | 2017 | 339 | 0.110 |
Why?
|
| Aged, 80 and over | 20 | 2024 | 58952 | 0.110 |
Why?
|
| Agammaglobulinemia | 1 | 2015 | 172 | 0.110 |
Why?
|
| Rib Fractures | 1 | 2014 | 128 | 0.110 |
Why?
|
| Parents | 2 | 2018 | 3564 | 0.110 |
Why?
|
| Th2 Cells | 1 | 2018 | 1071 | 0.110 |
Why?
|
| Neurodegenerative Diseases | 1 | 2022 | 1085 | 0.110 |
Why?
|
| Beverages | 1 | 2018 | 821 | 0.110 |
Why?
|
| Actigraphy | 1 | 2017 | 522 | 0.110 |
Why?
|
| Stomach Neoplasms | 1 | 2023 | 1457 | 0.100 |
Why?
|
| Obesity | 1 | 2015 | 12940 | 0.100 |
Why?
|
| Nutrition Surveys | 2 | 2022 | 1723 | 0.100 |
Why?
|
| Angioplasty, Balloon | 1 | 1997 | 589 | 0.100 |
Why?
|
| Spinal Neoplasms | 1 | 2019 | 703 | 0.100 |
Why?
|
| Liver Diseases | 1 | 2021 | 1301 | 0.100 |
Why?
|
| Young Adult | 16 | 2020 | 59222 | 0.100 |
Why?
|
| Adenoma | 1 | 2003 | 2159 | 0.100 |
Why?
|
| Echocardiography | 2 | 2023 | 5006 | 0.100 |
Why?
|
| Sensitivity and Specificity | 9 | 2019 | 14675 | 0.100 |
Why?
|
| Neoplasms, Connective and Soft Tissue | 1 | 2012 | 34 | 0.100 |
Why?
|
| Motor Skills | 1 | 2015 | 521 | 0.100 |
Why?
|
| Evidence-Based Medicine | 1 | 2024 | 3691 | 0.100 |
Why?
|
| Stomach | 2 | 2014 | 697 | 0.100 |
Why?
|
| Frail Elderly | 1 | 2017 | 766 | 0.100 |
Why?
|
| Checklist | 1 | 2019 | 828 | 0.100 |
Why?
|
| Hospital Costs | 1 | 1998 | 947 | 0.100 |
Why?
|
| Receptors, Cell Surface | 1 | 2021 | 2802 | 0.100 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2003 | 1726 | 0.100 |
Why?
|
| Opportunistic Infections | 1 | 2015 | 376 | 0.100 |
Why?
|
| Monocytes | 1 | 2021 | 2570 | 0.100 |
Why?
|
| Multimedia | 1 | 2012 | 75 | 0.100 |
Why?
|
| Mast Cells | 1 | 2019 | 1392 | 0.100 |
Why?
|
| Diffusion Tensor Imaging | 2 | 2013 | 2401 | 0.100 |
Why?
|
| Dermatitis, Atopic | 1 | 2019 | 731 | 0.100 |
Why?
|
| Biometry | 1 | 2015 | 563 | 0.100 |
Why?
|
| Family Health | 1 | 2016 | 1254 | 0.090 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2022 | 1462 | 0.090 |
Why?
|
| Biopsy, Needle | 3 | 2017 | 1624 | 0.090 |
Why?
|
| Running | 1 | 2016 | 487 | 0.090 |
Why?
|
| Nutritional Status | 1 | 2019 | 1597 | 0.090 |
Why?
|
| Osteosarcoma | 1 | 2017 | 896 | 0.090 |
Why?
|
| Endoscopy | 4 | 2016 | 1852 | 0.090 |
Why?
|
| Fixatives | 1 | 2011 | 90 | 0.090 |
Why?
|
| Food Hypersensitivity | 1 | 2019 | 726 | 0.090 |
Why?
|
| Connective Tissue | 1 | 2013 | 419 | 0.090 |
Why?
|
| Interleukin-10 | 1 | 2016 | 1176 | 0.090 |
Why?
|
| Thigh | 3 | 2017 | 239 | 0.090 |
Why?
|
| Pancreatic Neoplasms | 2 | 2012 | 5366 | 0.090 |
Why?
|
| Metabolome | 2 | 2023 | 989 | 0.090 |
Why?
|
| Horseshoe Crabs | 1 | 2010 | 13 | 0.090 |
Why?
|
| Methylation | 2 | 2024 | 1070 | 0.090 |
Why?
|
| Interleukin-1beta | 1 | 2016 | 1002 | 0.090 |
Why?
|
| Group Processes | 1 | 2012 | 228 | 0.090 |
Why?
|
| Health Status Disparities | 1 | 2022 | 1847 | 0.090 |
Why?
|
| Advisory Committees | 1 | 2015 | 788 | 0.090 |
Why?
|
| Paraffin Embedding | 1 | 2011 | 302 | 0.090 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2013 | 546 | 0.090 |
Why?
|
| Receptors, Progesterone | 3 | 2023 | 1129 | 0.090 |
Why?
|
| Surgical Procedures, Operative | 1 | 2022 | 1923 | 0.090 |
Why?
|
| Dementia | 1 | 2024 | 2684 | 0.090 |
Why?
|
| Breast Neoplasms | 2 | 2023 | 20982 | 0.090 |
Why?
|
| Joints | 1 | 2011 | 322 | 0.090 |
Why?
|
| Brain | 4 | 2021 | 27094 | 0.080 |
Why?
|
| Insulin-Secreting Cells | 1 | 2017 | 898 | 0.080 |
Why?
|
| Critical Pathways | 3 | 2018 | 475 | 0.080 |
Why?
|
| Neoplasms, Cystic, Mucinous, and Serous | 1 | 2012 | 194 | 0.080 |
Why?
|
| Predictive Value of Tests | 8 | 2019 | 15308 | 0.080 |
Why?
|
| Foreign-Body Reaction | 1 | 2010 | 157 | 0.080 |
Why?
|
| Microfilament Proteins | 1 | 2015 | 1130 | 0.080 |
Why?
|
| Granuloma, Plasma Cell | 1 | 2010 | 80 | 0.080 |
Why?
|
| Intraoperative Period | 2 | 2022 | 510 | 0.080 |
Why?
|
| Child Behavior | 1 | 2015 | 848 | 0.080 |
Why?
|
| ROC Curve | 4 | 2022 | 3584 | 0.080 |
Why?
|
| Cholangiopancreatography, Magnetic Resonance | 1 | 2010 | 100 | 0.080 |
Why?
|
| Myositis Ossificans | 1 | 2010 | 77 | 0.080 |
Why?
|
| Monte Carlo Method | 1 | 2015 | 1256 | 0.080 |
Why?
|
| Angiography | 1 | 2015 | 1597 | 0.080 |
Why?
|
| Meningeal Neoplasms | 1 | 2018 | 1246 | 0.080 |
Why?
|
| Blood-Brain Barrier | 2 | 2012 | 1028 | 0.080 |
Why?
|
| Foot Diseases | 1 | 2010 | 148 | 0.080 |
Why?
|
| Biliary Tract | 1 | 2010 | 135 | 0.080 |
Why?
|
| Cytokines | 1 | 2024 | 7386 | 0.080 |
Why?
|
| Cell Proliferation | 4 | 2019 | 10423 | 0.080 |
Why?
|
| Ethanol | 1 | 2015 | 1322 | 0.080 |
Why?
|
| MicroRNAs | 2 | 2017 | 3758 | 0.080 |
Why?
|
| Social Stigma | 1 | 2015 | 770 | 0.080 |
Why?
|
| Walking | 1 | 2016 | 1194 | 0.080 |
Why?
|
| Amino Acids | 1 | 1995 | 1703 | 0.080 |
Why?
|
| Prospective Studies | 11 | 2024 | 54437 | 0.080 |
Why?
|
| Solitary Fibrous Tumors | 1 | 2009 | 67 | 0.080 |
Why?
|
| Mucins | 1 | 2012 | 569 | 0.080 |
Why?
|
| Atherosclerosis | 1 | 2024 | 3407 | 0.080 |
Why?
|
| Calibration | 3 | 2017 | 819 | 0.080 |
Why?
|
| Robotics | 1 | 2015 | 817 | 0.080 |
Why?
|
| Edema | 2 | 2010 | 764 | 0.080 |
Why?
|
| Metabolomics | 2 | 2023 | 1658 | 0.080 |
Why?
|
| Follow-Up Studies | 6 | 2023 | 39127 | 0.080 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2017 | 1172 | 0.080 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 3 | 2013 | 3777 | 0.080 |
Why?
|
| Choristoma | 1 | 2010 | 205 | 0.080 |
Why?
|
| Exercise Therapy | 1 | 2015 | 922 | 0.080 |
Why?
|
| Medical Errors | 1 | 2016 | 1263 | 0.080 |
Why?
|
| Arthroplasty, Replacement | 1 | 2011 | 309 | 0.080 |
Why?
|
| Pancreatic Cyst | 1 | 2012 | 367 | 0.080 |
Why?
|
| Guidelines as Topic | 2 | 2017 | 1385 | 0.070 |
Why?
|
| Esophagoscopy | 1 | 2010 | 398 | 0.070 |
Why?
|
| Heart Transplantation | 2 | 2020 | 3258 | 0.070 |
Why?
|
| Upper Extremity | 2 | 2023 | 658 | 0.070 |
Why?
|
| Aortic Valve Stenosis | 1 | 2020 | 2018 | 0.070 |
Why?
|
| Hypersensitivity | 1 | 2017 | 1167 | 0.070 |
Why?
|
| Age Factors | 3 | 2020 | 18384 | 0.070 |
Why?
|
| Magnetic Resonance Imaging | 9 | 2014 | 36415 | 0.070 |
Why?
|
| Body Weight | 2 | 2015 | 4618 | 0.070 |
Why?
|
| Organoids | 2 | 2024 | 744 | 0.070 |
Why?
|
| Crohn Disease | 1 | 2020 | 2278 | 0.070 |
Why?
|
| Prevalence | 3 | 2020 | 15721 | 0.070 |
Why?
|
| Musculoskeletal Diseases | 1 | 2013 | 598 | 0.070 |
Why?
|
| Urease | 1 | 2007 | 39 | 0.070 |
Why?
|
| Parkinson Disease | 1 | 2021 | 2867 | 0.070 |
Why?
|
| Pattern Recognition, Automated | 1 | 2013 | 993 | 0.070 |
Why?
|
| Attitude to Health | 1 | 2015 | 2026 | 0.070 |
Why?
|
| Endoscopy, Gastrointestinal | 2 | 2018 | 876 | 0.070 |
Why?
|
| Heart-Assist Devices | 1 | 2017 | 1288 | 0.070 |
Why?
|
| Prognosis | 10 | 2020 | 29688 | 0.070 |
Why?
|
| Adolescent Behavior | 1 | 2015 | 1188 | 0.070 |
Why?
|
| Neoplasm Recurrence, Local | 3 | 2023 | 9278 | 0.070 |
Why?
|
| Laparotomy | 1 | 2009 | 456 | 0.070 |
Why?
|
| Wounds, Penetrating | 1 | 2009 | 314 | 0.070 |
Why?
|
| Multiple Sclerosis, Relapsing-Remitting | 1 | 2012 | 556 | 0.070 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2017 | 2131 | 0.070 |
Why?
|
| Income | 1 | 2015 | 1869 | 0.070 |
Why?
|
| Gastroenteritis | 1 | 2008 | 236 | 0.070 |
Why?
|
| Enterocolitis, Pseudomembranous | 1 | 2008 | 264 | 0.070 |
Why?
|
| Developmental Disabilities | 1 | 2015 | 1510 | 0.070 |
Why?
|
| Colony Count, Microbial | 1 | 2007 | 328 | 0.070 |
Why?
|
| Calorimetry, Indirect | 2 | 2017 | 173 | 0.070 |
Why?
|
| Collagen | 1 | 2014 | 2635 | 0.070 |
Why?
|
| Blood Glucose | 2 | 2017 | 6392 | 0.060 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2013 | 1838 | 0.060 |
Why?
|
| Foreign Bodies | 1 | 2010 | 402 | 0.060 |
Why?
|
| Postoperative Complications | 4 | 2022 | 15637 | 0.060 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2011 | 788 | 0.060 |
Why?
|
| Portal System | 1 | 2005 | 49 | 0.060 |
Why?
|
| Gastroscopy | 2 | 2023 | 211 | 0.060 |
Why?
|
| Infant, Newborn | 6 | 2023 | 26200 | 0.060 |
Why?
|
| Contrast Media | 3 | 2015 | 5311 | 0.060 |
Why?
|
| Breath Tests | 1 | 2007 | 299 | 0.060 |
Why?
|
| Mice | 12 | 2024 | 81330 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2009 | 726 | 0.060 |
Why?
|
| Pilot Projects | 3 | 2016 | 8642 | 0.060 |
Why?
|
| Oligodeoxyribonucleotides, Antisense | 1 | 2005 | 57 | 0.060 |
Why?
|
| Heart Diseases | 2 | 1998 | 2795 | 0.060 |
Why?
|
| Cross-Sectional Studies | 5 | 2024 | 26072 | 0.060 |
Why?
|
| Vancomycin | 1 | 2008 | 503 | 0.060 |
Why?
|
| Patient Care Management | 1 | 2008 | 303 | 0.060 |
Why?
|
| Accreditation | 1 | 2008 | 473 | 0.060 |
Why?
|
| Risk Assessment | 2 | 2022 | 24022 | 0.060 |
Why?
|
| Pregnancy | 7 | 2023 | 29893 | 0.060 |
Why?
|
| Students | 1 | 2015 | 1737 | 0.060 |
Why?
|
| Longitudinal Studies | 2 | 2018 | 14610 | 0.060 |
Why?
|
| Ultrasonography, Interventional | 1 | 2013 | 1496 | 0.060 |
Why?
|
| Diagnostic Errors | 1 | 2012 | 1265 | 0.060 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 2 | 2019 | 5321 | 0.060 |
Why?
|
| Phosphoproteins | 1 | 2013 | 2444 | 0.060 |
Why?
|
| Image Enhancement | 2 | 2013 | 2888 | 0.060 |
Why?
|
| Animals | 17 | 2024 | 168089 | 0.060 |
Why?
|
| Single-Blind Method | 2 | 2019 | 1577 | 0.060 |
Why?
|
| Tomography, X-Ray Computed | 8 | 2017 | 20588 | 0.060 |
Why?
|
| Radiation Tolerance | 2 | 2004 | 478 | 0.060 |
Why?
|
| Mass Spectrometry | 1 | 2011 | 2189 | 0.060 |
Why?
|
| Teaching | 1 | 2012 | 1171 | 0.060 |
Why?
|
| Incidence | 5 | 2021 | 21366 | 0.060 |
Why?
|
| Carotid Body Tumor | 1 | 2004 | 34 | 0.060 |
Why?
|
| Neurilemmoma | 1 | 2009 | 523 | 0.060 |
Why?
|
| Thyroid Neoplasms | 1 | 2017 | 2330 | 0.060 |
Why?
|
| Molybdenum | 1 | 2024 | 45 | 0.060 |
Why?
|
| Cohort Studies | 7 | 2023 | 41496 | 0.060 |
Why?
|
| Stromal Cells | 1 | 2009 | 1329 | 0.060 |
Why?
|
| Risk Factors | 8 | 2022 | 74241 | 0.060 |
Why?
|
| Chemokines, CXC | 1 | 2005 | 416 | 0.060 |
Why?
|
| Agar | 1 | 2023 | 51 | 0.060 |
Why?
|
| Cobalt | 1 | 2024 | 148 | 0.060 |
Why?
|
| Health Care Costs | 1 | 1997 | 3239 | 0.050 |
Why?
|
| Insulin Resistance | 1 | 2017 | 3952 | 0.050 |
Why?
|
| Arachidonic Acids | 1 | 2023 | 294 | 0.050 |
Why?
|
| Abdominal Pain | 2 | 2023 | 1067 | 0.050 |
Why?
|
| Nickel | 1 | 2024 | 126 | 0.050 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2013 | 2897 | 0.050 |
Why?
|
| Clarithromycin | 1 | 2023 | 86 | 0.050 |
Why?
|
| Thyroidectomy | 2 | 2017 | 908 | 0.050 |
Why?
|
| Receptors, Neurokinin-1 | 1 | 2023 | 134 | 0.050 |
Why?
|
| Cecum | 1 | 2023 | 233 | 0.050 |
Why?
|
| Software | 1 | 2017 | 4431 | 0.050 |
Why?
|
| Pandemics | 1 | 2023 | 8663 | 0.050 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2012 | 1072 | 0.050 |
Why?
|
| Cholecystitis | 1 | 2003 | 180 | 0.050 |
Why?
|
| Food, Fortified | 1 | 2023 | 189 | 0.050 |
Why?
|
| Reference Standards | 2 | 2017 | 1005 | 0.050 |
Why?
|
| Time Factors | 5 | 2021 | 39957 | 0.050 |
Why?
|
| Heart Rate | 1 | 2014 | 4197 | 0.050 |
Why?
|
| Pancreatic Diseases | 1 | 2004 | 345 | 0.050 |
Why?
|
| Halogenated Diphenyl Ethers | 1 | 2022 | 82 | 0.050 |
Why?
|
| Abnormalities, Multiple | 1 | 2010 | 1423 | 0.050 |
Why?
|
| Nitrogen Oxides | 1 | 2022 | 129 | 0.050 |
Why?
|
| Substance P | 1 | 2023 | 334 | 0.050 |
Why?
|
| Recurrence | 2 | 2016 | 8457 | 0.050 |
Why?
|
| Amoxicillin | 1 | 2023 | 181 | 0.050 |
Why?
|
| Receptors, Estrogen | 2 | 2023 | 2208 | 0.050 |
Why?
|
| Medicaid | 2 | 2012 | 2813 | 0.050 |
Why?
|
| Metronidazole | 1 | 2023 | 232 | 0.050 |
Why?
|
| Vascular Endothelial Growth Factors | 1 | 2003 | 748 | 0.050 |
Why?
|
| Bangladesh | 1 | 2024 | 732 | 0.050 |
Why?
|
| Myosin Heavy Chains | 1 | 2023 | 403 | 0.050 |
Why?
|
| Brain Ischemia | 1 | 2015 | 3032 | 0.050 |
Why?
|
| Expert Testimony | 2 | 2015 | 365 | 0.050 |
Why?
|
| Choline | 1 | 2023 | 515 | 0.050 |
Why?
|
| Paresis | 1 | 2023 | 176 | 0.050 |
Why?
|
| Neoplasms | 5 | 2014 | 22142 | 0.050 |
Why?
|
| Myocardial Infarction | 2 | 2021 | 11476 | 0.050 |
Why?
|
| Myocardium | 1 | 2014 | 4746 | 0.050 |
Why?
|
| Immunocompetence | 1 | 2021 | 138 | 0.050 |
Why?
|
| Patient Care Team | 2 | 2012 | 2515 | 0.050 |
Why?
|
| Treatment Outcome | 11 | 2020 | 64681 | 0.050 |
Why?
|
| Nerve Net | 1 | 2013 | 2288 | 0.050 |
Why?
|
| Boston | 4 | 2017 | 9327 | 0.050 |
Why?
|
| Electrocardiography | 1 | 2014 | 6387 | 0.050 |
Why?
|
| Manganese | 1 | 2024 | 391 | 0.050 |
Why?
|
| Muscle Development | 1 | 2002 | 258 | 0.050 |
Why?
|
| Creatine | 1 | 2023 | 427 | 0.050 |
Why?
|
| Calcitonin Gene-Related Peptide | 1 | 2023 | 323 | 0.050 |
Why?
|
| Societies, Medical | 2 | 2014 | 3923 | 0.050 |
Why?
|
| Nausea | 1 | 2023 | 678 | 0.040 |
Why?
|
| Noise | 1 | 2023 | 290 | 0.040 |
Why?
|
| New England | 1 | 2023 | 1052 | 0.040 |
Why?
|
| Remission Induction | 2 | 2019 | 2392 | 0.040 |
Why?
|
| Mutation | 5 | 2018 | 30004 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 5 | 2021 | 22128 | 0.040 |
Why?
|
| Sarcoma, Synovial | 1 | 2002 | 153 | 0.040 |
Why?
|
| Genitalia | 1 | 2021 | 113 | 0.040 |
Why?
|
| Epidemiologic Studies | 1 | 2024 | 677 | 0.040 |
Why?
|
| Cities | 1 | 2023 | 541 | 0.040 |
Why?
|
| HLA-DQ Antigens | 1 | 2020 | 190 | 0.040 |
Why?
|
| Metals | 1 | 2024 | 711 | 0.040 |
Why?
|
| Serum Amyloid A Protein | 1 | 2000 | 126 | 0.040 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2008 | 1803 | 0.040 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2014 | 8998 | 0.040 |
Why?
|
| Apolipoprotein E4 | 1 | 2024 | 709 | 0.040 |
Why?
|
| Intelligence Tests | 1 | 2021 | 503 | 0.040 |
Why?
|
| Mice, Knockout | 3 | 2024 | 14392 | 0.040 |
Why?
|
| Immunoglobulin A | 1 | 2023 | 979 | 0.040 |
Why?
|
| Ganciclovir | 1 | 2000 | 253 | 0.040 |
Why?
|
| Denmark | 1 | 2022 | 770 | 0.040 |
Why?
|
| Cytomegalovirus | 2 | 2021 | 750 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 2 | 2013 | 471 | 0.040 |
Why?
|
| Anti-Bacterial Agents | 3 | 2023 | 7407 | 0.040 |
Why?
|
| GPI-Linked Proteins | 1 | 2021 | 470 | 0.040 |
Why?
|
| Esophageal Neoplasms | 1 | 2010 | 1658 | 0.040 |
Why?
|
| Zinc | 1 | 2024 | 672 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 2 | 2013 | 475 | 0.040 |
Why?
|
| Sequence Analysis, RNA | 2 | 2021 | 2011 | 0.040 |
Why?
|
| Single-Cell Analysis | 2 | 2021 | 2452 | 0.040 |
Why?
|
| Receptors, CXCR4 | 1 | 2024 | 727 | 0.040 |
Why?
|
| Antigens, CD34 | 1 | 2001 | 655 | 0.040 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2003 | 830 | 0.040 |
Why?
|
| Islets of Langerhans | 1 | 2005 | 1342 | 0.040 |
Why?
|
| Cognition Disorders | 1 | 2013 | 3976 | 0.040 |
Why?
|
| Gene Expression Profiling | 4 | 2017 | 9417 | 0.040 |
Why?
|
| Lung Neoplasms | 2 | 2019 | 13386 | 0.040 |
Why?
|
| Carbon Monoxide | 1 | 2022 | 547 | 0.040 |
Why?
|
| Sarcoidosis | 1 | 2004 | 537 | 0.040 |
Why?
|
| HEK293 Cells | 2 | 2021 | 4243 | 0.040 |
Why?
|
| Agricultural Workers' Diseases | 1 | 1998 | 28 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2015 | 17897 | 0.040 |
Why?
|
| Cognition | 3 | 2024 | 6988 | 0.040 |
Why?
|
| Microarray Analysis | 1 | 2021 | 748 | 0.040 |
Why?
|
| Exercise Test | 2 | 2017 | 2165 | 0.040 |
Why?
|
| Budesonide | 1 | 2019 | 158 | 0.040 |
Why?
|
| Fruit | 1 | 2024 | 1158 | 0.040 |
Why?
|
| Epithelium | 2 | 2018 | 1603 | 0.040 |
Why?
|
| Vegetables | 1 | 2024 | 1192 | 0.040 |
Why?
|
| Double-Blind Method | 2 | 2024 | 12341 | 0.040 |
Why?
|
| Chemotaxis | 1 | 2021 | 598 | 0.040 |
Why?
|
| Blotting, Western | 2 | 2002 | 5032 | 0.040 |
Why?
|
| Hypoxia-Inducible Factor 1 | 1 | 2018 | 193 | 0.040 |
Why?
|
| Lead | 1 | 2024 | 879 | 0.040 |
Why?
|
| Liver | 2 | 2021 | 7512 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 12 | 1 | 2019 | 430 | 0.040 |
Why?
|
| Survival Analysis | 3 | 2018 | 10088 | 0.040 |
Why?
|
| Area Under Curve | 1 | 2022 | 1636 | 0.040 |
Why?
|
| Public Health | 2 | 2022 | 2672 | 0.040 |
Why?
|
| Asthma | 1 | 2016 | 6230 | 0.040 |
Why?
|
| Vehicle Emissions | 1 | 2022 | 655 | 0.040 |
Why?
|
| North America | 1 | 2021 | 1284 | 0.040 |
Why?
|
| Carbonated Beverages | 1 | 2018 | 210 | 0.040 |
Why?
|
| Insulin | 2 | 2017 | 6588 | 0.040 |
Why?
|
| T-Lymphocytes | 1 | 2015 | 10203 | 0.040 |
Why?
|
| Utah | 1 | 2017 | 130 | 0.040 |
Why?
|
| Medicare | 2 | 2012 | 6774 | 0.040 |
Why?
|
| Leg | 2 | 1992 | 1087 | 0.040 |
Why?
|
| Disease Susceptibility | 1 | 2024 | 1791 | 0.040 |
Why?
|
| Brain Neoplasms | 1 | 2018 | 9025 | 0.040 |
Why?
|
| Gastric Inhibitory Polypeptide | 1 | 2017 | 68 | 0.030 |
Why?
|
| Infant Formula | 1 | 2018 | 194 | 0.030 |
Why?
|
| Nitrogen Dioxide | 1 | 2020 | 521 | 0.030 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2023 | 1936 | 0.030 |
Why?
|
| Microscopy, Electron | 1 | 2000 | 2561 | 0.030 |
Why?
|
| Interleukin-13 | 1 | 2019 | 392 | 0.030 |
Why?
|
| Interleukin-10 Receptor alpha Subunit | 1 | 2016 | 28 | 0.030 |
Why?
|
| Sigmoidoscopy | 1 | 2017 | 151 | 0.030 |
Why?
|
| Depression | 1 | 2016 | 8132 | 0.030 |
Why?
|
| Dura Mater | 1 | 2018 | 290 | 0.030 |
Why?
|
| Incretins | 1 | 2017 | 99 | 0.030 |
Why?
|
| Chicago | 1 | 1997 | 254 | 0.030 |
Why?
|
| Gliadin | 1 | 2016 | 80 | 0.030 |
Why?
|
| Oropharyngeal Neoplasms | 1 | 2002 | 491 | 0.030 |
Why?
|
| Intelligence | 1 | 2021 | 922 | 0.030 |
Why?
|
| Caspase 8 | 1 | 2016 | 190 | 0.030 |
Why?
|
| Heart Failure | 1 | 2020 | 11701 | 0.030 |
Why?
|
| Diagnostic Techniques, Digestive System | 1 | 2016 | 45 | 0.030 |
Why?
|
| Neutropenia | 1 | 2021 | 885 | 0.030 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2020 | 4373 | 0.030 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2023 | 1048 | 0.030 |
Why?
|
| Neovascularization, Pathologic | 2 | 2018 | 2636 | 0.030 |
Why?
|
| Disease Models, Animal | 4 | 2024 | 18222 | 0.030 |
Why?
|
| Aging | 1 | 2015 | 8702 | 0.030 |
Why?
|
| Survival Rate | 4 | 2020 | 12728 | 0.030 |
Why?
|
| Milk | 1 | 2018 | 440 | 0.030 |
Why?
|
| Cost Control | 1 | 1998 | 627 | 0.030 |
Why?
|
| Blood Vessels | 1 | 2021 | 1111 | 0.030 |
Why?
|
| Gadolinium DTPA | 2 | 2012 | 823 | 0.030 |
Why?
|
| Phagocytosis | 1 | 2021 | 1525 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2017 | 4340 | 0.030 |
Why?
|
| Wrist | 1 | 2017 | 226 | 0.030 |
Why?
|
| Dyspnea | 1 | 2023 | 1347 | 0.030 |
Why?
|
| Aminoisobutyric Acids | 1 | 1995 | 39 | 0.030 |
Why?
|
| Propensity Score | 1 | 2023 | 1916 | 0.030 |
Why?
|
| DNA Methylation | 2 | 2021 | 4384 | 0.030 |
Why?
|
| Discriminant Analysis | 1 | 2015 | 224 | 0.030 |
Why?
|
| Maternal Exposure | 1 | 2022 | 1067 | 0.030 |
Why?
|
| Interleukin-4 | 1 | 2019 | 1154 | 0.030 |
Why?
|
| Intestine, Small | 1 | 2021 | 1207 | 0.030 |
Why?
|
| Pain | 1 | 2010 | 5072 | 0.030 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 1 | 2016 | 299 | 0.030 |
Why?
|
| Factor Analysis, Statistical | 1 | 2017 | 998 | 0.030 |
Why?
|
| Transglutaminases | 1 | 2016 | 196 | 0.030 |
Why?
|
| Pregnancy Complications | 1 | 2009 | 2949 | 0.030 |
Why?
|
| Cross-Over Studies | 1 | 2021 | 2082 | 0.030 |
Why?
|
| Gastrins | 1 | 2014 | 75 | 0.030 |
Why?
|
| Microdialysis | 1 | 1995 | 161 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 2 | 2019 | 6200 | 0.030 |
Why?
|
| Chemokine CCL11 | 1 | 2014 | 128 | 0.030 |
Why?
|
| Hyperplasia | 2 | 2010 | 1150 | 0.030 |
Why?
|
| Spinal Cord | 1 | 2023 | 1807 | 0.030 |
Why?
|
| Inflammation Mediators | 1 | 2023 | 1885 | 0.030 |
Why?
|
| Thoracic Vertebrae | 1 | 2019 | 612 | 0.030 |
Why?
|
| Colitis, Collagenous | 1 | 2014 | 25 | 0.030 |
Why?
|
| Tenascin | 1 | 2014 | 61 | 0.030 |
Why?
|
| Age of Onset | 1 | 2021 | 3307 | 0.030 |
Why?
|
| Endometrium | 1 | 2017 | 403 | 0.030 |
Why?
|
| Canada | 1 | 2020 | 2125 | 0.030 |
Why?
|
| Pancreatectomy | 2 | 2012 | 811 | 0.030 |
Why?
|
| Fatal Outcome | 1 | 2019 | 1838 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2003 | 4111 | 0.030 |
Why?
|
| Temperature | 1 | 2021 | 2219 | 0.030 |
Why?
|
| Sensation Disorders | 1 | 2015 | 158 | 0.030 |
Why?
|
| Tibial Arteries | 1 | 1994 | 60 | 0.030 |
Why?
|
| Inservice Training | 1 | 1997 | 375 | 0.030 |
Why?
|
| Interleukins | 1 | 2019 | 782 | 0.030 |
Why?
|
| Lymphocyte Count | 1 | 2016 | 781 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 3 | 2009 | 6125 | 0.030 |
Why?
|
| Melanoma | 2 | 2009 | 5694 | 0.030 |
Why?
|
| Baltimore | 1 | 2014 | 231 | 0.030 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2003 | 2820 | 0.030 |
Why?
|
| China | 1 | 2020 | 2374 | 0.030 |
Why?
|
| DNA, Viral | 1 | 2000 | 2195 | 0.030 |
Why?
|
| Liver Transplantation | 1 | 2005 | 2332 | 0.030 |
Why?
|
| Length of Stay | 2 | 1998 | 6417 | 0.030 |
Why?
|
| Unnecessary Procedures | 1 | 2017 | 418 | 0.030 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2004 | 2871 | 0.030 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2002 | 1605 | 0.030 |
Why?
|
| Phosphorylation | 3 | 2013 | 8300 | 0.030 |
Why?
|
| Thyroid Gland | 1 | 2000 | 1169 | 0.030 |
Why?
|
| Uric Acid | 1 | 2019 | 807 | 0.030 |
Why?
|
| Nursing Staff, Hospital | 1 | 1997 | 348 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2020 | 3803 | 0.030 |
Why?
|
| Homozygote | 1 | 2018 | 1775 | 0.030 |
Why?
|
| Reactive Oxygen Species | 1 | 2021 | 2138 | 0.030 |
Why?
|
| Guinea Pigs | 1 | 1995 | 1308 | 0.030 |
Why?
|
| Sodium Dodecyl Sulfate | 1 | 2013 | 124 | 0.030 |
Why?
|
| Phospholipase C gamma | 1 | 2013 | 131 | 0.030 |
Why?
|
| Alzheimer Disease | 1 | 2014 | 8606 | 0.030 |
Why?
|
| ras Proteins | 2 | 2012 | 1055 | 0.030 |
Why?
|
| Locomotion | 1 | 2015 | 388 | 0.030 |
Why?
|
| Immunoglobulin E | 1 | 2019 | 1505 | 0.030 |
Why?
|
| Popliteal Vein | 1 | 1992 | 43 | 0.030 |
Why?
|
| Injections, Intravenous | 1 | 1995 | 1376 | 0.030 |
Why?
|
| Aspartic Acid | 1 | 1995 | 574 | 0.030 |
Why?
|
| Chronic Disease | 2 | 2018 | 9319 | 0.030 |
Why?
|
| Arterial Occlusive Diseases | 2 | 1994 | 749 | 0.030 |
Why?
|
| Data Collection | 1 | 2022 | 3320 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-akt | 3 | 2009 | 2455 | 0.030 |
Why?
|
| Epithelioid Cells | 1 | 2012 | 60 | 0.030 |
Why?
|
| Mucin-2 | 1 | 2012 | 50 | 0.030 |
Why?
|
| Arm | 1 | 2015 | 589 | 0.020 |
Why?
|
| Observer Variation | 1 | 2018 | 2610 | 0.020 |
Why?
|
| Efficiency, Organizational | 1 | 2016 | 695 | 0.020 |
Why?
|
| Femoral Vein | 1 | 1992 | 153 | 0.020 |
Why?
|
| Mucin 5AC | 1 | 2012 | 96 | 0.020 |
Why?
|
| GTP-Binding Proteins | 1 | 2016 | 946 | 0.020 |
Why?
|
| Serum | 1 | 2013 | 208 | 0.020 |
Why?
|
| Hospitals, Teaching | 1 | 2016 | 1155 | 0.020 |
Why?
|
| Anaphylaxis | 1 | 2019 | 758 | 0.020 |
Why?
|
| DNA, Neoplasm | 1 | 2017 | 1743 | 0.020 |
Why?
|
| Workflow | 1 | 2016 | 850 | 0.020 |
Why?
|
| Neuropsychological Tests | 1 | 2024 | 7046 | 0.020 |
Why?
|
| Glycine | 1 | 1995 | 659 | 0.020 |
Why?
|
| Sex Factors | 2 | 2015 | 10553 | 0.020 |
Why?
|
| Gene Deletion | 1 | 2019 | 2658 | 0.020 |
Why?
|
| Iliac Artery | 1 | 1993 | 343 | 0.020 |
Why?
|
| Genetic Markers | 1 | 2017 | 2599 | 0.020 |
Why?
|
| Inflammasomes | 1 | 2016 | 526 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 1 | 2008 | 9187 | 0.020 |
Why?
|
| Leukocytes | 1 | 2019 | 2025 | 0.020 |
Why?
|
| Pulsatile Flow | 1 | 2012 | 320 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1995 | 1535 | 0.020 |
Why?
|
| C-Reactive Protein | 2 | 2013 | 3821 | 0.020 |
Why?
|
| Cells, Cultured | 2 | 2017 | 18927 | 0.020 |
Why?
|
| Early Diagnosis | 1 | 2016 | 1186 | 0.020 |
Why?
|
| Angiography, Digital Subtraction | 1 | 2012 | 335 | 0.020 |
Why?
|
| False Negative Reactions | 1 | 2012 | 573 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2023 | 3634 | 0.020 |
Why?
|
| Muscle Strength | 1 | 2015 | 624 | 0.020 |
Why?
|
| Allergens | 1 | 2018 | 1433 | 0.020 |
Why?
|
| Energy Intake | 1 | 2018 | 2133 | 0.020 |
Why?
|
| Apoptosis | 3 | 2017 | 9478 | 0.020 |
Why?
|
| Potassium | 1 | 1995 | 1309 | 0.020 |
Why?
|
| Pneumocystis | 1 | 1990 | 55 | 0.020 |
Why?
|
| Osteomyelitis | 1 | 2014 | 407 | 0.020 |
Why?
|
| Aortic Valve | 1 | 2020 | 1959 | 0.020 |
Why?
|
| Interleukin-17 | 1 | 2016 | 913 | 0.020 |
Why?
|
| Antigens, Fungal | 1 | 1990 | 69 | 0.020 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2013 | 597 | 0.020 |
Why?
|
| Breast Feeding | 1 | 2018 | 1356 | 0.020 |
Why?
|
| Adenosine Triphosphate | 1 | 2016 | 1988 | 0.020 |
Why?
|
| Expert Systems | 1 | 2010 | 79 | 0.020 |
Why?
|
| Secretin | 1 | 2010 | 57 | 0.020 |
Why?
|
| Forearm | 1 | 2012 | 427 | 0.020 |
Why?
|
| Protein Array Analysis | 1 | 2011 | 399 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2013 | 1518 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2015 | 2665 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 2016 | 2359 | 0.020 |
Why?
|
| Common Bile Duct | 1 | 2010 | 106 | 0.020 |
Why?
|
| Substrate Specificity | 1 | 2013 | 1768 | 0.020 |
Why?
|
| Risk | 1 | 2022 | 9616 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2020 | 5871 | 0.020 |
Why?
|
| Mitochondria | 1 | 2023 | 3620 | 0.020 |
Why?
|
| Age Distribution | 1 | 2015 | 2871 | 0.020 |
Why?
|
| False Positive Reactions | 1 | 2012 | 958 | 0.020 |
Why?
|
| Tumor Stem Cell Assay | 1 | 2009 | 115 | 0.020 |
Why?
|
| Lower Extremity | 1 | 2017 | 1201 | 0.020 |
Why?
|
| Genetic Vectors | 2 | 2013 | 3388 | 0.020 |
Why?
|
| Pedigree | 1 | 2017 | 4537 | 0.020 |
Why?
|
| Microscopy | 1 | 2014 | 904 | 0.020 |
Why?
|
| Protein Biosynthesis | 1 | 2016 | 2091 | 0.020 |
Why?
|
| Glutamic Acid | 1 | 1995 | 1173 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2013 | 1602 | 0.020 |
Why?
|
| Databases, Nucleic Acid | 1 | 2010 | 205 | 0.020 |
Why?
|
| Phenotype | 2 | 2021 | 16575 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2017 | 3590 | 0.020 |
Why?
|
| Adenoviridae | 1 | 2013 | 1084 | 0.020 |
Why?
|
| Cost-Benefit Analysis | 2 | 2012 | 5493 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2021 | 9520 | 0.020 |
Why?
|
| Cell Line, Tumor | 2 | 2017 | 16954 | 0.020 |
Why?
|
| Reaction Time | 1 | 2015 | 2087 | 0.020 |
Why?
|
| Lipopolysaccharides | 1 | 2016 | 2199 | 0.020 |
Why?
|
| Genes, APC | 1 | 2009 | 145 | 0.020 |
Why?
|
| Pneumonia, Pneumocystis | 1 | 1990 | 242 | 0.020 |
Why?
|
| Femoral Artery | 1 | 1993 | 826 | 0.020 |
Why?
|
| Synaptic Transmission | 1 | 1995 | 1167 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2017 | 2475 | 0.020 |
Why?
|
| Neutrophils | 1 | 2021 | 3763 | 0.020 |
Why?
|
| Kidney Neoplasms | 1 | 2005 | 4251 | 0.020 |
Why?
|
| Mortality | 1 | 2020 | 2896 | 0.020 |
Why?
|
| Bile Ducts | 1 | 2010 | 284 | 0.020 |
Why?
|
| Problem-Based Learning | 1 | 2012 | 356 | 0.020 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 1995 | 1139 | 0.020 |
Why?
|
| International Cooperation | 1 | 2015 | 1423 | 0.020 |
Why?
|
| Activities of Daily Living | 1 | 2017 | 2420 | 0.020 |
Why?
|
| Insurance, Health, Reimbursement | 1 | 2011 | 385 | 0.020 |
Why?
|
| Antiviral Agents | 1 | 2000 | 3048 | 0.020 |
Why?
|
| Educational Status | 1 | 2015 | 2510 | 0.020 |
Why?
|
| Interferon-gamma | 1 | 2016 | 3155 | 0.020 |
Why?
|
| Spectrum Analysis | 1 | 2010 | 449 | 0.020 |
Why?
|
| Radiography, Thoracic | 1 | 2014 | 1302 | 0.020 |
Why?
|
| Protein Transport | 1 | 2013 | 1958 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2017 | 8531 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2013 | 3577 | 0.020 |
Why?
|
| Chromatography, Liquid | 1 | 2011 | 982 | 0.020 |
Why?
|
| Autoantibodies | 1 | 2016 | 2119 | 0.020 |
Why?
|
| Mucin-1 | 1 | 2012 | 538 | 0.020 |
Why?
|
| Duodenoscopy | 1 | 2007 | 45 | 0.020 |
Why?
|
| Homeodomain Proteins | 1 | 2016 | 2414 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2013 | 3418 | 0.020 |
Why?
|
| Ankle | 1 | 2010 | 350 | 0.020 |
Why?
|
| Administration, Oral | 2 | 2008 | 4015 | 0.020 |
Why?
|
| Logistic Models | 1 | 2022 | 13249 | 0.020 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 2010 | 506 | 0.020 |
Why?
|
| Gene Expression Regulation | 2 | 2016 | 11855 | 0.020 |
Why?
|
| Guideline Adherence | 1 | 2017 | 2220 | 0.020 |
Why?
|
| Equipment Design | 1 | 2015 | 3510 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2017 | 4138 | 0.020 |
Why?
|
| Antirheumatic Agents | 1 | 2016 | 1369 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2013 | 3606 | 0.020 |
Why?
|
| Psychometrics | 1 | 2016 | 3061 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2017 | 6819 | 0.020 |
Why?
|
| Cell Movement | 1 | 2018 | 5195 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2023 | 10218 | 0.020 |
Why?
|
| Genetic Variation | 1 | 2021 | 6567 | 0.020 |
Why?
|
| Primary Health Care | 1 | 2023 | 4679 | 0.020 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2002 | 4021 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2017 | 4739 | 0.020 |
Why?
|
| Base Sequence | 1 | 2017 | 12404 | 0.020 |
Why?
|
| Dumping Syndrome | 1 | 2005 | 18 | 0.020 |
Why?
|
| Referral and Consultation | 1 | 2019 | 3608 | 0.020 |
Why?
|
| Angioplasty, Balloon, Coronary | 1 | 1993 | 1724 | 0.020 |
Why?
|
| Endosonography | 1 | 2010 | 608 | 0.020 |
Why?
|
| Chemokine CXCL5 | 1 | 2005 | 27 | 0.020 |
Why?
|
| Diazoxide | 1 | 2005 | 52 | 0.020 |
Why?
|
| Diet | 1 | 2024 | 8048 | 0.020 |
Why?
|
| Salvage Therapy | 1 | 1992 | 1264 | 0.020 |
Why?
|
| Skin | 1 | 2019 | 4473 | 0.020 |
Why?
|
| Stem Cells | 1 | 2018 | 3517 | 0.020 |
Why?
|
| RNA Interference | 1 | 2013 | 2816 | 0.020 |
Why?
|
| Models, Neurological | 1 | 2013 | 1769 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2017 | 8519 | 0.020 |
Why?
|
| Registries | 2 | 2017 | 8246 | 0.020 |
Why?
|
| Cooperative Behavior | 1 | 2012 | 1506 | 0.010 |
Why?
|
| Socioeconomic Factors | 1 | 2018 | 7804 | 0.010 |
Why?
|
| Octreotide | 1 | 2005 | 154 | 0.010 |
Why?
|
| Organ Preservation | 1 | 1988 | 382 | 0.010 |
Why?
|
| Diet Therapy | 1 | 2005 | 151 | 0.010 |
Why?
|
| Immunity, Innate | 1 | 2016 | 3044 | 0.010 |
Why?
|
| Antigens, Neoplasm | 1 | 2012 | 1985 | 0.010 |
Why?
|
| Bacterial Infections | 1 | 1992 | 1390 | 0.010 |
Why?
|
| Immunoenzyme Techniques | 2 | 2002 | 1703 | 0.010 |
Why?
|
| Europe | 1 | 2011 | 3423 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 2015 | 5478 | 0.010 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2018 | 4014 | 0.010 |
Why?
|
| Surgical Flaps | 1 | 1992 | 1670 | 0.010 |
Why?
|
| Family | 1 | 2014 | 3192 | 0.010 |
Why?
|
| Reoperation | 2 | 2010 | 4303 | 0.010 |
Why?
|
| Program Evaluation | 1 | 2012 | 2489 | 0.010 |
Why?
|
| Ischemia | 1 | 1992 | 1889 | 0.010 |
Why?
|
| Genes, erbB-2 | 1 | 2004 | 162 | 0.010 |
Why?
|
| Gangrene | 1 | 2003 | 91 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2017 | 7571 | 0.010 |
Why?
|
| Life Tables | 2 | 1994 | 364 | 0.010 |
Why?
|
| Genes, erbB-1 | 1 | 2004 | 162 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2015 | 10756 | 0.010 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2013 | 2270 | 0.010 |
Why?
|
| Neurosurgical Procedures | 1 | 2014 | 2067 | 0.010 |
Why?
|
| Cluster Analysis | 1 | 2010 | 2706 | 0.010 |
Why?
|
| Severity of Illness Index | 2 | 2013 | 15841 | 0.010 |
Why?
|
| Intraoperative Complications | 1 | 1989 | 1164 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 2 | 2003 | 6067 | 0.010 |
Why?
|
| Radiography | 1 | 2014 | 6974 | 0.010 |
Why?
|
| Bone and Bones | 1 | 2013 | 2568 | 0.010 |
Why?
|
| Immunoglobulin G | 1 | 2014 | 4537 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2017 | 12474 | 0.010 |
Why?
|
| Granuloma | 1 | 2004 | 326 | 0.010 |
Why?
|
| Carbon Dioxide | 1 | 2007 | 1147 | 0.010 |
Why?
|
| Appendicitis | 1 | 2009 | 676 | 0.010 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2017 | 3627 | 0.010 |
Why?
|
| Gene Expression | 1 | 2015 | 7571 | 0.010 |
Why?
|
| Chromones | 1 | 2002 | 148 | 0.010 |
Why?
|
| Odds Ratio | 1 | 2014 | 9652 | 0.010 |
Why?
|
| Gallbladder | 1 | 2003 | 308 | 0.010 |
Why?
|
| Calcium | 1 | 1995 | 5719 | 0.010 |
Why?
|
| Macrophages | 1 | 2016 | 5755 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 18 | 1 | 2002 | 247 | 0.010 |
Why?
|
| Suspensions | 1 | 2000 | 66 | 0.010 |
Why?
|
| Surgical Wound Infection | 1 | 2010 | 1530 | 0.010 |
Why?
|
| Antibodies, Bacterial | 1 | 2007 | 1464 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2004 | 4513 | 0.010 |
Why?
|
| Capsules | 1 | 2000 | 191 | 0.010 |
Why?
|
| Computational Biology | 1 | 2012 | 3499 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 1 | 2003 | 558 | 0.010 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2002 | 880 | 0.010 |
Why?
|
| Mucous Membrane | 1 | 2003 | 659 | 0.010 |
Why?
|
| Graft Occlusion, Vascular | 2 | 1994 | 537 | 0.010 |
Why?
|
| Kidney Failure, Chronic | 1 | 1992 | 2478 | 0.010 |
Why?
|
| Steroids | 1 | 2004 | 929 | 0.010 |
Why?
|
| DNA Primers | 1 | 2003 | 2814 | 0.010 |
Why?
|
| Necrosis | 1 | 2003 | 1610 | 0.010 |
Why?
|
| Ultrasonography | 1 | 2012 | 5969 | 0.010 |
Why?
|
| Cocarcinogenesis | 1 | 1998 | 49 | 0.010 |
Why?
|
| Drug Tolerance | 1 | 2000 | 367 | 0.010 |
Why?
|
| Morpholines | 1 | 2002 | 581 | 0.010 |
Why?
|
| Lung Transplantation | 1 | 1988 | 1307 | 0.010 |
Why?
|
| Lymph Node Excision | 1 | 2004 | 1270 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 2008 | 6304 | 0.010 |
Why?
|
| X Chromosome | 1 | 2002 | 816 | 0.010 |
Why?
|
| Neoplasm Staging | 2 | 2004 | 11119 | 0.010 |
Why?
|
| Drug Resistance, Microbial | 1 | 2000 | 826 | 0.010 |
Why?
|
| Pancreatitis | 1 | 2004 | 1081 | 0.010 |
Why?
|
| Acquired Immunodeficiency Syndrome | 2 | 2000 | 2196 | 0.010 |
Why?
|
| Genome, Human | 1 | 2010 | 4423 | 0.010 |
Why?
|
| Transplantation, Homologous | 1 | 2005 | 4822 | 0.010 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2015 | 5666 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2017 | 11733 | 0.010 |
Why?
|
| Israel | 1 | 1998 | 718 | 0.010 |
Why?
|
| Translocation, Genetic | 1 | 2002 | 1391 | 0.010 |
Why?
|
| Diagnostic Imaging | 1 | 2010 | 3534 | 0.010 |
Why?
|
| Stroke Volume | 1 | 1989 | 5521 | 0.010 |
Why?
|
| Pesticides | 1 | 1998 | 296 | 0.010 |
Why?
|
| Quinazolines | 1 | 2002 | 1371 | 0.010 |
Why?
|
| Hepatitis C | 1 | 2005 | 1579 | 0.010 |
Why?
|
| Immunocompromised Host | 1 | 2000 | 858 | 0.010 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2010 | 5301 | 0.010 |
Why?
|
| Cell Division | 1 | 2002 | 4451 | 0.010 |
Why?
|
| Comorbidity | 1 | 2009 | 10516 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2013 | 12101 | 0.010 |
Why?
|
| Cell Survival | 1 | 2003 | 5778 | 0.010 |
Why?
|
| Acute Disease | 1 | 2003 | 7226 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2000 | 4851 | 0.010 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2002 | 2864 | 0.010 |
Why?
|
| Ovarian Neoplasms | 1 | 2008 | 4872 | 0.010 |
Why?
|
| Cell Line | 1 | 2005 | 15545 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2002 | 3702 | 0.010 |
Why?
|
| Neoplasm Metastasis | 1 | 2002 | 4909 | 0.010 |
Why?
|
| Adenocarcinoma | 1 | 2008 | 6341 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2013 | 13632 | 0.010 |
Why?
|
| Veins | 1 | 1994 | 767 | 0.010 |
Why?
|
| Transplantation, Autologous | 1 | 1994 | 2112 | 0.010 |
Why?
|
| Anastomosis, Surgical | 1 | 1992 | 982 | 0.000 |
Why?
|
| Arteriovenous Shunt, Surgical | 1 | 1992 | 290 | 0.000 |
Why?
|
| Occupational Exposure | 1 | 1998 | 1814 | 0.000 |
Why?
|
| Cell Differentiation | 1 | 2002 | 11512 | 0.000 |
Why?
|
| HIV-1 | 1 | 2000 | 6851 | 0.000 |
Why?
|
| Dogs | 1 | 1988 | 3832 | 0.000 |
Why?
|
| Smoking | 1 | 1998 | 9055 | 0.000 |
Why?
|
| Wound Healing | 1 | 1992 | 2800 | 0.000 |
Why?
|
| Tissue and Organ Procurement | 1 | 1988 | 963 | 0.000 |
Why?
|